Anteris Technologies Ownership
AMEUF Stock | USD 8.28 0.03 0.36% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Anteris |
Anteris Pink Sheet Ownership Analysis
About 13.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.15. Anteris Technologies had not issued any dividends in recent years. The entity had 1:10 split on the 17th of November 2015. Anteris Technologies Ltd operates as a structural heart company. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Admedus operates under Medical Devices classification in the United States and is traded on OTC Exchange.The quote for Anteris Technologies is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Anteris Technologies please contact the company at 61 13 0055 0310 or go to https://www.anteristech.com.Currently Active Assets on Macroaxis
Other Information on Investing in Anteris Pink Sheet
Anteris Technologies financial ratios help investors to determine whether Anteris Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anteris with respect to the benefits of owning Anteris Technologies security.